-+ 0.00%
-+ 0.00%
-+ 0.00%

Oncotelic to present PDAOAI drug discovery platform at Drug Discovery & Lead Optimization conference

PUBT·10/05/2026 12:09:43
Listen to the news
Oncotelic to present PDAOAI drug discovery platform at Drug Discovery & Lead Optimization conference
  • Oncotelic will present at the 10th International Conference on Drug Discovery & Lead Optimization on Oct. 7-9, 2026, in Burlingame, California.
  • Product Manager Scott Myers is scheduled to give a keynote on Oct. 7, 2026, 11:20-11:50 a.m. PT, on AI search aggregation.
  • Chief Business Officer Saran Saund is set to deliver a keynote on Oct. 8, 2026, 10:00-10:30 a.m. PT, on an HCC gene signature.
  • Saund is also slated to join an AI-focused drug discovery panel on Oct. 8, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncotelic Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610050800PRIMZONEFULLFEED9838375) on October 05, 2026, and is solely responsible for the information contained therein.